NCI, Advisers Lean To Smaller Increases For R01a, Philosophy Of Spreading Money Among More Grants
In Brief: Cancer Series Helps Do In Woodward As Post Metro Editor; OCC RFP Canceled, to Reappear As 4-5 RFPs
Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief
Four New DCCP Abs Established Without New Slots, More Money
ACCC Annual Meeting Expands to 4 Days, One On Cancer Control
CHOP Evaluation Plan In Jan. 22 Issue
Smoking Conference Established Priorities
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









